| Original language | English (US) |
|---|---|
| Pages (from-to) | 2106-2109 |
| Number of pages | 4 |
| Journal | JACC: Cardiovascular Interventions |
| Volume | 12 |
| Issue number | 20 |
| DOIs | |
| State | Published - Oct 28 2019 |
| Externally published | Yes |
Keywords
- MINOCABG
- cardiac magnetic resonance
- culprit vessel
- myocardial infarction
- optical coherence tomography
ASJC Scopus subject areas
- Cardiology and Cardiovascular Medicine
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: JACC: Cardiovascular Interventions, Vol. 12, No. 20, 28.10.2019, p. 2106-2109.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Finding the Culprit
T2 - Combining Cardiac Magnetic Resonance Imaging With Optical Coherence Tomography
AU - Xenogiannis, Iosif
AU - Lin, David
AU - Lesser, John R.
AU - Hall, Allison B.
AU - Cavalcante, João L.
AU - Brilakis, Emmanouil S.
AU - Gössl, Mario
N1 - Funding Information: Dr. Cavalcante has received research support from Medtronic, Edwards Lifesciences, Boston Scientific, Siemens, and Abbott Vascular; has been a consultant for Boston Scientific, Abbott Vascular, and Siemens; and has received speakers fees from Siemens. Dr. Brilakis has received consulting/speaker honoraria from Abbott Vascular, American Heart Association (associate editor Circulation ), Boston Scientific, Cardiovascular Innovations Foundation (board of directors), CSI, Elsevier, GE Healthcare, InfraRedx, and Medtronic; has received research support from Regeneron and Siemens; is a shareholder in MHI Ventures; and has served on the board of trustees of the Society of Cardiovascular Angiography and Interventions. Dr. Gössl has been a consultant for Abbott Vascular and Caisson/Livanova; and has received research grants from Edwards Lifesciences. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose. Images in Intervention Funding Information: Dr. Cavalcante has received research support from Medtronic, Edwards Lifesciences, Boston Scientific, Siemens, and Abbott Vascular; has been a consultant for Boston Scientific, Abbott Vascular, and Siemens; and has received speakers fees from Siemens. Dr. Brilakis has received consulting/speaker honoraria from Abbott Vascular, American Heart Association (associate editor Circulation), Boston Scientific, Cardiovascular Innovations Foundation (board of directors), CSI, Elsevier, GE Healthcare, InfraRedx, and Medtronic; has received research support from Regeneron and Siemens; is a shareholder in MHI Ventures; and has served on the board of trustees of the Society of Cardiovascular Angiography and Interventions. Dr. G?ssl has been a consultant for Abbott Vascular and Caisson/Livanova; and has received research grants from Edwards Lifesciences. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
PY - 2019/10/28
Y1 - 2019/10/28
KW - MINOCABG
KW - cardiac magnetic resonance
KW - culprit vessel
KW - myocardial infarction
KW - optical coherence tomography
UR - http://www.scopus.com/inward/record.url?scp=85073154376&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85073154376&partnerID=8YFLogxK
U2 - 10.1016/j.jcin.2019.07.035
DO - 10.1016/j.jcin.2019.07.035
M3 - Article
C2 - 31563676
AN - SCOPUS:85073154376
SN - 1936-8798
VL - 12
SP - 2106
EP - 2109
JO - JACC: Cardiovascular Interventions
JF - JACC: Cardiovascular Interventions
IS - 20
ER -